AcquisitionOther

Lineage Cell Therapeutics, Inc. acquired NeuroAirmid Therapeutics, Inc.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Lineage Cell Therapeutics, Inc. -> NeuroAirmid Therapeutics, Inc. · $16 million

“While our collaboration with Roche and Genentech for the development of the OpRegen cell therapy program for dry AMD with geographic atrophy continues to advance, we are focused on using our platform to build a diversified portfolio of additional allogeneic c

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk